Research Journal of Pharmacology
ISSN: Online 1993-6019ISSN: Print 1815-9362
Abstract
Corona viruses is RNA virus, and classified within the Coronaviridae family and falls under the Nidoviridae family. Its significance as a public health concern escalated following the outbreak of Severe Acute Respiratory Syndrome Corona virus (SARS‐CoV) in the city of Wuhan, Hubei Province, China, in December 2019. Following the notification of the index case in China, the first confirmed case of CoViD‐19 was reported in January 2020 in India. Effectiveness of corona virus disease‐19 (COVID‐19) vaccines used in India is unexplored and need to be substantiated. In the meantime, serum institute of India, Pune starts the chase for the vaccine and by the end of the year, they come along with the Covishield (Oxford/Astra Zeneca vaccine manufactured by Serum Institute of India) vaccine. Studies describing the effect of the Covishield vaccine are scars. The objective of the study was to find the effectiveness of the Covishield vaccine. In this study we included the RT‐PCR confirmed 328 Covid infection hospitalised patients, from January 2021‐June 2021 (includes Frontline workers, Police staff, Teachers and Elderly etc.), from age group 20‐75, who were admitted in Goberdhan Tiwari Base Hospital Almora Uttarakhand along with their vaccination status. In vaccinated group of 117 individuals 104(88.88%) were recovered from hospitalisation but in the non‐vaccinated group of 211 individuals 110 (52.13%) were recovered and 101 (47.87%) were deceased. We concluded that Vaccinated individuals recover rapidly as compared to the non‐vaccinated individuals.
How to cite this article:
Pratibha Pandey, Hemant Kumar Dutt, Abhinav Manish and Amit Kumar Singh. Estimation of Effectiveness of the Covishield Vaccine.
DOI: https://doi.org/10.36478/10.36478/makrjp.2024.1.53.57
URL: https://www.makhillpublications.co/view-article/1815-9362/10.36478/makrjp.2024.1.53.57